Brand Name:

Rivaro

Generic Name:

Rivaroxaban

Composition:

Rivaro 2.5mg Tablet:
Each film-coated tablet contains: Rivaroxaban 2.5 m
Rivaro 10mg Tablet:
Each film-coated tablet contains: Rivaroxaban 10mg
Rivaro 15mg Tablet:
Each film-.coated tablet contains: Rivaroxaban 15m
Rivaro 20mg Tablet:
Each film-coated tablet contains: Rivaroxaban 20mg

Description:

A selective inhibitor of FXa. It does not require a cofactor (such as Anti-thrombin III) for activity. Rivaro inhibits free FXa and prothrombinase activity. Rivaroxaban has no direct effect on platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin. By inhibiting FXa, rivaroxaban decreases thrombin generation.

INDICATIONS:

Nonvalvular Atrial Fibrillation, Treatment of DVT and/or PE, Reduction in the Risk of Recurrence of DVT and/or PE, Prophylaxis of DVT Following Hip or Knee Replacement Surgery, Prophylaxis of VTE in Acutely Ill Medical Patients at Risk for Thromboembolic Complications, CAD or PAD

PRESENTATION:

Rivaro 2.5mg Tablets: Alu. Alu. Blister Pack of 1 x 14’s.
Rivaro 10 mg Tablets: Alu. Alu. Blister Pack of 1 x 10’s.
Rivaro 15 mg Tablets: Alu. Alu. Blister Pack of 1 x 14’s.
Rivaro 20 mg Tablets: Alu. Alu. Blister Pack of 1 x 14’s